NTS071

· Nutshell Therapeutics (Shanghai) Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTS071, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation [Phase 1, Phase 2]

See pricing